Pharmacognosy Research logo
Submit
Pharmacognosy ResearchACADEMIC PUBLISHING
Article

Serum total antioxidant capacity in oral carcinoma patients

1, 2★, 3★ Corresponding author

  1. 1Departments of Otorhinolaryngology
  2. 2Microbiology, Mahatma Gandhi Medical College and Research Institute, Puducherry
  3. 3Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India

CORRESPONDENCE

Arunava Kali

Microbiology, Mahatma Gandhi Medical College and Research Institute, Puducherry

ak.arunava@gmail.com

Volume 7, Issue 2 · pp. 184-187 · 2015 · DOI: 10.4103/0974-8490.150513

ABSTRACT

Oxidative stress is a major determinant in carcinogenesis and serum total antioxidant capacity (TAC) indirectly reflects the level of oxidative stress. Although oral cancer is the third most frequent cancer in Indian population, there are no standard noninvasive marker for early detection and monitoring therapeutic response in oral cancer patients. This study was carried out to investigate implications of serum TAC in oral cancer by evaluating pre- and post-operative levels in oral cancer patients. It was a prospective single blinded study. Serum TAC was measured using ferric-reducing antioxidant power assay. Pre- and post-operative values were estimated and compared in 30 oral cancer patients who underwent surgery. Paired t-test was used to compare pre- and post-operative values. Compared to the normal value, both pre- and post-operative serum TAC were significantly low in oral cancer patients. However, there was no statistically significant difference between pre- and postoperative levels. In this study, low mean serum TAC was detected in oral cancer patients. However, its diagnostic and prognostic significance in oral cancer needs further investigation.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Shetty, K. S. R., Kali, A., & Shetty, K. S. R. (2015). Serum total antioxidant capacity in oral carcinoma patients. Pharmacognosy Research, 7(2), 184-187. https://doi.org/10.4103/0974-8490.150513

    Copyright and licence

    © 2015 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0